This increase in BMPR2 levels might be a feedback mechanism to restore endogenous BMP signaling and prevent disease progression, a process that has failed in the end-stage lung tissue of iPAH patients. This evidence concerns the gene BMPR2 and idiopathic pulmonary arterial hypertension.